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Introduction
Yeast as an Organism for Genetic Studies
Yeasts provide a useful and versatile tool
for studying genetic phenomena. The gene-
tics of Saccharomyces cerevisia.e has been in-
tensively studied for many years, and as a
result considerable information has been ac-
cumulated. Excellent current and compre-
hensive reviews on the genetics of yeast are
available (1, 2), including one that is par-
ticularly directed toward studies of dele-
terious genetic effects of chemicals (3).
Yeasts are eukaryotic organisms and there-
fore contain a nucleus and cytoplasm con-
taining various other differentiated organel-
les quite similar to other higher life forms
(4). The genetic apparatus consists of at
least 17 chromosomes in the haploid S.
cerevisiae identified by genetic mapping
(5). Thus the structural organization of the
genetic information is analogous to that in
other higher life forms. Equally important
is the well-known life cycle in yeast which,
genetically, provides for classical mitotic
and meiotic functions such as those existing
in differentiated cells of more complex mul-
ticellular organisms. Yeasts, as well as all
higher life forms, contain extrachromosom-
al DNA which provides essential genetic in-
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formation exclusive of the classical Men-
delian pattern. S. cerevisiae is a particularly
well-suited organism for the investiga-
tion of this little understood phenomenon.
In addition to the basic biological nature
of yeasts, a number of practical considera-
tions make these organisms particularly
amenable for studies of the potential effects
of chemicals on genetic events. Yeasts are
routinely handled by using standard micro-
biological techniques such as cloning, replica
plating, and micromanipulation. They grow
rapidly, having short generation times, on
inexpensive culture media, permitting accu-
mulation of more than 109 cells from a sin-
gle Petri dish culture within 2-3 days. On
such media yeast divide mitotically by bud-
ding, which results in single isolated cells;
therefore, the chance of a genetic change
going undetected is minimized. There are
numerous genetic markers available, includ-
ing biochemical lesions, repair functions,
suppressors, and regulatory functions, many
of which are useful for studying chemically
induced genetic effects (1, 6, 7). The organ-
ism can be cultivated as a haploid, permit-
ting mutation induction studies unhamper-
ed by considerations of the dominance or
recessive nature of the mutation. Stable di-
ploids and even higher ploidy can be readi-
ly constructed for studies involving such
events as mitotic crossing-over and gene con-
version. The mitotic and meiotic cycles can
be interchanged in diploid Saccharomyces
merely by changing the culture conditions.
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satile organisms in which the effects of
chemicals can be studied for their impact
on the range of known genetic phenomena
occurring in all eukaryotic life forms.
Some Current Concepts of Genetic Safety
Screening
Geneticists interested in the problem of
chemical mutagenesis have become increas-
ingly aware that the metabolic activities in
the animal have great impact on the fate
of many potentially deleterious chemicals.
Microorganisms apparently lack the requi-
site enzyme systems to metabolize many po-
tentially genetically active compounds, and
as a result such tests are negative. The is-
sue has been clouded, therefore, by earlier
studies involving microorganisms as the
genetic indicator system.
In cases where the proximally active
metabolites have been discovered, isolated,
and then tested in microorganisms, they
have been shown to cause genetic damage.
Thus, in many instances, direct testing on
genetic systems in microorganisms provides
insufficient evidence to conclude that a
compound is genetically harmless. Current
methodology has brought us to the point
where we can surmount these metabolic de-
ficiencies in microorganisms. As indicated
above, the genetically active breakdown pro-
duct, if it is defined and reasonably stable,
can be tested directly in the microorganism.
Additional systems providing metabolic ac-
tivity namely; (1) in vitro hydroxylation,
(2) liver microsome preparations, and (3)
host-mediated assays, will be described in
this communication with special note to
their applicability to S. cerevisiae genetic
systems.
In our laboratories several specific lines of
investigation are currently being pursued.
These include forward and reverse mutation
studies in haploid as well as reciprocal and
nonreciprocal mitotic recombination in dip-
loid S. cerevisiae. Since most of the chemi-
cals whose genetic effects will be described
in this paper are recognized carcinogens, the
induction of deleterious genetic events in
yeast may have relevance to the question to
the mechanism of cancer induction.
In Vitro Genetic Assays
Qualitative Plate Tests: Forward and Re-
verse Mutation and Mitotic Gene Conversion
A significant proportion of the chemicals
currently being screened for genetic activ-
ity are tested in qualitative plate tests. Pro-
cedures have been described for the detec-
tion of lambda phage induction (8) reverse
mutation in Salmonella typhimurium (9)
and Escherichia coli (10), and mitotic gene
conversion and reverse mutation induction
in S. cerevisiae (11-13). Some serious limi-
tations are associated with this approach to
safety screening of chemical agents; for ex-
ample, chemicals requiring metabolic acti-
vation prior to exhibiting genetic activity
would appear negative in plate tests, as
would compounds which have weak genetic
activity. In addition, most of the systems in
use have been built around the reversion of
specific mutational alterations carried by
the indicator organisms employed, which
theoretically limits the types of compounds
that can be detected in the assay to those
capable of reverting the lesions in the indi-
cator cells. Some technical modifications are
being introduced in plate tests which should
significantly increase their usefulness. These
involve the utilization of hepatic drug-
metabolizing enzymes for the potentiation
of certain chemicals (14), construction of
highly sensitive indicator strains through
alterations in their capacity to repair gene-
tic damage or limit permeability of specific
molecules (15), and the development on non-
restrictive assays such as mitotic gene con-
version (11) or forward mutation. An ap-
propriate forward mutation test would per-
mit the detection of all classes of mutagenic
alterations.
A technique that we have been working
with permits the detection of forward muta-
tion at an arginine-specific permease locus
in S. cerevisiae. A mutational block in this
gene renders the cell resistant-to an arginine
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step plate test is conducted as follows. (1). - detecting forward and reverse mutation
Approximately 10 cells of the prototrophic and mitotic gene conversion.
haploid strain S228C are spread on plates of
yeast complete agar (17) and allowed to dry.
(2) an aliquot or a few crystals of the test
chemicals are added to the plates. Solvent, if
used, is added to the control plates. (3)
Treated and control plates are incubated for
24 hr at 300 C. (4) Following this incuba-
tion, the plates are replica-plated to yeast
minimal medium (18) containing canava-
nine sulfate (Calbiochem) at 30 Jug/ml. (5)
The canavanine plates are then incubated
for 5 days at 300 C and scored for the number
of canavanine-resistant colonies.
The advantages of this method are that
apparently both frameshift and base-pair
substitution events can be detected (19) and
that the indicator organisms are exposed to
the test chemical during several rounds of
cell division, permitting the chemical to act
on replicating DNA.
The results shown in Table 1 summarize
our plate test studies with a large number of
chemicals screened for forward and reverse
mutation induction as well as for mitotic
gene conversion.
The auxotrophic mutants used in the re-
verse mutation tests are classified as base-
pair substitution (S211) and frameshift
(S138) on the basis of extensive reversion
tests with known frameshift and base-pair
substitution mutagens.
Mitotic Recombination: Crossing Over and
Gene Conversion
Mitotic recombination (reciprocal
crossing-over and non-reciprocal gene gcon-
version) probably occurs in all eukaryotic
diploid organisms. It has been observed in
Saccharomyces (20), Aspergillus (21), Pen-
icillium (22), Ustilago (23), Drosophila
(24), and probably in mammals (25,26) in-
cluding man (27). Many chemicals which
are carcinogenic and mutagenic also induce
mitotic crossing-over (28-31) and gene con-
version (11,32-37). Thus chemically in-
duced mitotic recombination can serve as an
indicator of genetic damage (38,11).
Compound
MMS
EMS
.MNNG
ENNG
Diethyl sulfate
Nitrosomethylurea
Nitrosomethylurethane
,8-Propiolactone
Nitrogen mustard
Triethylene melamine
Cyclophosphamide
DMNA
DENA
Hydroxylamine
Nitroquinoline N-oxide
Hycanthone
ICR-170.E e
ICR-191.D e
Sodium nitrite
Quinacrine
Proflavine e
2-Aminopurine
5-Bromodeoxyuridine
Mitotic
gene
conver-
sion a b
+
+
+
NT
NT
NT
NT
+
NT
+
NT
+
±
+
NT
NT
NT
NT
NT
Forward
muta-
tion b c
+
+
NT
NT
+
NT
Reverse
mutation d
FS BPS
+ +
- +
- +
+
_ +
+
+ +
+
- +
+ -
± -
a MMS = methyl methanesulfonate; EMS = ethyl
methanesulfonate; MNNG = N-methyl-N'-nitro-N-
nitrosoguanidine; ENNG = N-ethyl-N'-nitro-N-ni-
trosoguanidine; DMNA = dimethylnitrosamine;
DENA= diethylnitrosamine; ICR-170 = 2-methoxy-
6-chloro-9-[3-(ethyl-2-chloroethyl) aminopropylami-
no]acridine dihydrochloride; ICR-191 = 2-methoxy-
6-chloro-9-[3-(2-chloroethyl)amino-propylamino]acri-
dine dihydrochloride.
b Mitotic gene conversion at the try 5 locus in
strain D-4.
c Forward mutation from canavanine-sensitive to
canavanine-resistant in strain S288C.
d Reverse mutation in the met-auxotrophs S211
BPS (base-pair substitution) and S138 FS (frame-
shift).
eCompound requires testing medium to be adjusted
to pH 7.0.
The potential result of mitotic recombina-
tion is the generation of a new genotype by
exchange of genetic material between homo-
logous chromosomes followed by appropri-
ate segregation of the products of mitosis.
The consequence of such an event in a cell is
the expression of a recessive phenotype in
the homozygous condition which would oth-
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85erwise go undetected in the heterozygous
state. Where carcinogenesis is shown to be a
genetic phenomenon, mitotic recombination
might serve as a mechanism to explain the
origins of some tumors. The extended latent
period commonly associated with tumor for-
mation could conceptually be due to a heter-
ozygous mutant "cancer gene" which is not
expressed until later in life when mitotic re-
combination renders this gene homozygous.
Mitotic recombination could likewise play a
role in the aging process, as recessive homo-
zygotes are continually and slowly generated
in individuals throughout life.
A very simple system has been developed
in S. cerevisiae strain D-3 for the detection
of mitotic crossing-over or reciprocal recom-
bination. A homozygous phenotype induced
in the heterozygous diploid is the primary
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criterion for crossing-over. The ade 2
marker is particularly useful in this respect
because the mutant allele results in the ac-
cumulation of a red pigment when homo-
zygous but is recessive when heterozygous.
Thus, mitotic crossing-over resulting in
homozygosity of the axde 2 marker can be
detected as a red sector in a normally white
colony. Other genetic phenomena such as
mutation or gene conversion could also re-
sult in expression of the recessive pheno-
type, so further testing is often desirable.
With crossing-over, reciprocal homozygous
products are obtained in each of the two
daughter cells of mitosis. The particular di-
ploid strain we use provides for this, since it
has two flanking heterozygous markers
around the axe 2 gene which can be tested
in a limited population for induction of
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FIGURE 1. Induction of mitotic crossing-over and mitotic gene conversion in yeast by
(-) MMS (0.1o), (-), MNNG (25 ,ug/ml), and (--) EMS (5.0%): (A) strain
D-4; (B) strain D-3.
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FIGURE 2. Induction"of mitotic crossing-over and-mitotic. gene conversion in yeast by
( ) hycanthone (1 mg/mi), (- ) ICR 170 (10 jug/ml), and '(--) uItraviolet lighti-
(10 ergs/mm2 sec): (A) strain D-4; (B) strain D-3.
homozygosity in allPtfiree markers simul- volving alteration of a small number of
taneously. nucleotide pairs within a single gene that
A complete deAcription of the particular can generate a wildtyp-e allelat either of
strain and the methods for its manipulation the two heteroallelic sites (36). This results
and handling have been extensively de- in the expression of a functional gene and
scribed (29-31). The details of the tech- the loss of the nutritional requirement.
niques used to obtain the mitotic crossing- The results presented in Figures 1-3 and
over data presented in this paper are de- Table 2 compare the induction of mitotic
scribed by Mayer (39). recombination in the strains D-3 and D-4
Mitotic gene conversion can be detected in under identical treatment conditions. Each
strain D-4, a diploid strain of S. cerevisiae curve, except those for hycanthone and cy-
heteroallelic at the ade 2 and try 5 loci. clophosphamide, is the result of three inde-
These alleles are stable and show low fre- pendent experiments. The hycanthone re-
quencies of revertibility (33). Both heteroal- sults (Fig. 2 and Table 2) and the cyclo-
lelic loci result in nutritional deficiencies phosphamide curves (Fig. 3) represent the
(noncomplementing) prohibiting the cells results of two independent experiments
from growing on either minimal or single each. Nonreciprocal recombination was as-
supplemented media. Mitotic gene conver- sayed at both the ade 2 and try 5 sites of
sion is a nonreciprocal event, probably in- strain D-4 in all experiments. Since the re-
100
10
It,
C
C
C
a:
0
zp.
-
zip
CA
- V)
LJ
I"
I
December 1973 87100
C 0
10
C
C
:4
tA
a
,Z
_,-
60 120 180
MINUTES TREATMENT
FIGURE 3. Induction of mitotic (
mitotic gene conversion in yeast
mide: ( ) strain D-4; (--) st
sults were not significantly di
two sites and since the resu
consistent at the try 5 site, c
were included in graphs or ta
that the events detected in
sulted from reciprocal recomi
than some other lesion whicl
in the production of red sect
gene conversion, haploidizati
junction), red and white port
sulting colony were analyze(
markers (29-31,39). In all of
were studied, the results v;
with the induction of recipro(
Except for slight differE
ICR-170 and ultraviolet ligh
2), the induction of recombi
types are roughly the same
agent.
Three compounds, ICR-174
and cyclophosphamide, have
been reported to induce mito
tion in vitro and will be disc
detail.
ICR-170, 2-methoxy-6-chlor
chloroethyl)aminopropylamino]acridine di-
hydrochloride, is one of a series of poten-
tial antineoplastic compounds synthesized
by Creech and co-workers (40). Many com-
pounds of this series (including ICR-170)
.0 exhibit mutagenic activity in a wide range
of organisms. ICR-170 is a potent recom-
binogen (Fig. 2) for both reciprocal and
nonreciprocal events. ICR-191, 2-methoxy-6-
chloro-9[3- (2-chloroethyl) aminopropylami-
no]acridine dihydrochloride, which is highly
mutagenic for bacteria, and ICR-170 are also
positive in the D-4 plate test (Table 1). Since
these compounds are generally recognized
as frameshift mutagens, it appears that
mitotic recombination can be induced by
frameshift as well as base-pair substitution
240300 360 mutagens. Fahrig (41) has also reported in- duction of nonreciprocal recombination in
strain D-4 with acridine dyes.
Derivatives of hyeanthone are potent an-
crossing-over and tishistosomiasis drugs which have been
by cyclophospha- shown to be mutagenic in bacteria (42),
;rain D-3. yeast (43), Drosophila (44) and animal
cells (45). Cytological and teratogenic ef-
ifferent for the fects have also been reported for some of
ilts were more these derivatives (46,47). The results shown
)nly these data in Figure 2 indicate that this compound has
bles. To insure a weak but significant recombinogenic ac-
strain D-3 re- tivity, especially for D-3. In several experi- bination rather ments with hycanthone we observed that its
h might result genetic activity was time- and pH-dependent
hors (mutation to a certain degree. A concentration of 1.0
on or nondis- mg/ml at pH 7.0 gave extreme cytotoxicity
;ions of the re- and only weak genetic activity; therefore, i for flanking two lower doses were tested over a 4-hr in-
the cases that cubation at pH 7.0 (Table 2). These tests
vere consistent confirmed the recombinogenic activity of 7erconsistents hycanthone for the reciprocal recombina- cal events. tion but left serious doubts as to its efficacy mces between for the induction of nonreciprocal events.
nation of both Because hycanthone did produce a positive nation fof
bh sresponse in the D-4 plate test, we are con-
,for a single ducting additional tests to determine what
0, hycanthone, environmental factors are required to ob-
not previously tain an accurate assessment of the activity
tic recombina- of this agent in D-4.
2ussed in some Cyclophosphamide (Cytoxan) is used
chemotherapeutically against many types of
o-9[3-(ethyl-2- tumors and metabolized by the mixed func-
Environmental Health Perspectives 88Table 2. Induction of mitotic recombination in
strains D-3 and D-4 with hycanthone at
concentrations of 0.01 and
0.10 mg/mi.
Recombi-
Survival, nants/10'
C/10 Survivors
Treatment
Tete D-F3 D-4 D-3 D-4
Control 10& 100 12. 5
Hycanthone, 0.01 mg/mi 67 100 26 3
Hycanthone, 0.10 mg/mi 32 67 92 6
tion oxidase enzymes of the liver to a cyclic
nitrogen mustard (48). Chromosome dam-
age (49) and recombinogenic activity by a
urine-excreted metabolite (50,51) have been
reported for this chemical. The results
shown in Figure 3 indicate that a signifi-
cant recombinogenic activity in D-3 is ob-
served with cyclophosphamide in vitro. No
induction of nonreciprocal events was ob-
served in the in vitro tests which is consis-
tent with other published observations (50,
51). The potent activity of this compound
for the induction of mitotic recombination
in strain D-3 without previous metabolic ac-
tivation was unexpected, and a more de-
tailed study of this compound is currently
under way.
In Vitro Hydroxylation System
Dimethylnitrosamine (DMNA) and
diethylnitrosamine (DENA) require con-
version to alkylating agents for their activ-
ity, presumably through a mechanism in-
volving an initial a-carbon hydroxylation
followed by spontaneous dealkylation (52-
55). Studies of aromatic amines indicate
that they are carcinogenic only after metab-
olic conversion by a hydroxylation mecha-
nism to active breakdown products (56).
Preussmann (57) showed that aliphatic ni-
trosamines can be hydroxylated by an
enzyme-free system that was originally de-
veloped by Udenfriend et al. (58) for the
ring-carbon hydroxylation of aromatic com-
pounds. Malling (59,60) and later Mayer
(61) demonstrated the formation of muta-
genic breakdown products from DMNA and
DENA using this system with Neurospora
and Sacchcaromyces, respectively. Recently,
Locke and Mayer (62) demonstrated by
physical and chemical methods that the
Udenfriend system was indeed capable of
dealkylation reactions. After the N-
hydroxy derivatives of 1-naphthylamine
(1-NA) and 2-naphthylamine (2-NA), but
not the parent compounds, were found to be
mutagenic for microorganisms (63-67),
Mayer (68) demonstrated that the break-
down products of 1-NA and 2-NA formed
in the Udenfriend hydroxylation system,
but not the parent compounds, were muta-
genic for Saccharomyces. More recently
DMNA, DENA, 1-NA, and 2-NA break-
down products have all been shown to in-
duce mitotic crossing-over in Saccharomy-
ces using the Udenfriend hydroxylation sys-
tem (39).
The research presented in this communi-
cation is an extention of these above find-
ings, including further studies on aliphatic
nitrosamines and aromatic amines. The
methodology has been previously reported
(39, 61, 68). Essentially, the procedures in-
volve simply incubating the genetic indicator
organism with the test chemical in the hydro-
xylation medium and removing cell samples
at appropriate time intervals to assay for in-
duced genetic events. Since the breakdown re-
actions require molecular oxygen, the effect
of breakdown products can be measured in
samples bubbled with 02 gas. Similar sam-
ples bubbled with N2 gas give results of
testing the parent compound for genetic
activity without breakdown.
Mitotic crossing-over was induced by
DMNA, DENA, di-n-propylnitrosamine
(DPNA) and di-n-butylnitrosamine
(DBNA) in the Udenfriend reaction mix-
ture in the presence of oxygen but not in
the presence of nitrogen (Fig. 4). Since the
reaction requires oxygen (57,58), these re-
sults indicate that the parent compounds are
inactive but that some breakdown products
are the genetically active entity. It is also
noteworthy (Fig. 4) that DENA breakdown
products induced crossing-over to a consider-
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FIGURE 4. Mitotic crossing-over induced in strain D-3
by breakdown products of aliphatic nitrosamines
formed in the Udenfriend hydroxylation medium.
ably greater extent than did DMNA, DPNA,
or DBNA. Likewise a relationship between
sector induction and time of treatment is
apparent for each compound. The homo-
logous secondary amines, dimethylamine
and diethylamine, which lack the nitroso
group of DMNA and DENA, did not induce
crossing-over under any test conditions
(39). The fact that they are not mutagenic
(61) indicates that the nitroso group is es-
sential for the genetic activity of DMNA
and DENA.
The induction of mitotic crossing-over by
breakdown products of three aromatic
amines, 2-aminobiphenyl, 4-aminobiphenyl,
and p-toluidine are shown in Figure 5.
Again, only samples of compound in the
Udenfriend reaction medium with oxygen
give responses above control values. Sur-
vival in all samples was 70% or higher.
Other aromatic amines, 1-NA and 2-NA,
were previously shown to induce mutation
(68) and mitotic crossing-over (39) in Sac-
charomyces with the Udenfriend reaction
FIGURE 5. Mitotic crossing-over induced in strain
D-3 by breakdown products of aromatic amines
formed in the Udenfriend hydroxylation medium.
medium only after breakdown in the pres-
ence of oxygen.
A representative sample of sectored colo-
nies induced by 2-aminobiphenyl, 4-aminob-
iphenyl, and p-toluidine were cloned for
their red and white portions. These were
each tested for induced homozygosity of a
flanking heterozygous marker on either side
of the ade 2 gene. The simultaneous induc-
tion of homozygosity in these three markers
was observed in the majority of samples,
further indicating that induction of the red
sectors by these chemicals was due to reci-
procal crossing-over and not to mutation or
gene conversion. Similar results have been
reported for DMNA, DENA, 1-NA, and 2-
NA (39).
In Vitro Liver Microsome Activation of
Chemical Mutagens
Malling (69) demonstrated that the
metabolites of DMNA could be formed by
exposure of the compound to mouse liver
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90microsomal enzymes in vitro as well as in
host-mediated or enzyme-free hydroxylation
tests. Ames et al. (14) have also used rat
and human liver microsomes to activate
chemical carcinogens in bacterial plate
tests. The addition of liver microsomal en-
zymes to in vitro assays has not only proven
to be a convenient technique to screen large
numbers of chemicals for genetic activity
but is also a potentially valuable method for
quantitatively comparing the metabolic ca-
pacities of different species, or individuals
within a species, to convert a given com-
pound to its genetically active state.
We have developed an in vitro liver micro-
some assay in our laboratory and have been
using both bacteria and yeast as indicator
organisms. Chemical carcinogens and muta-
gens have been activated by microsomes ob-
tained from several rodent and primate spe-
cies. The system uses the 9,000 g superna-
tant from liver homogenates prepared in
0.25M sucrose. A single run is conducted in
a 50-ml prescription bottle with a final vol-
ume of 1.8 ml. This includes the reaction
mixture, test chemical, microsome fraction
and the indicator cells. A typical test with
DMNA and strain D-3 is shown in Table 3.
Pure 02 is blown into the bottle, and it is
then incubated at 37°C for 60 min lying on
its side to provide maximum exposure of the
fluid to the 02. All dilutions and platings are
the same as those used in host-mediated and
normal in vitro tests.
The results of tests with DMNA and
DENA are shown in Table 4. Neither of
these compounds are recombinogenic in vi-
tro without metabolic activation.
Table 3. In vitro liver microsomal assay with yeast
as indicator organisms.
Concentration,
Component ml-'
TPN (sodium salt) 6,umole
Isocitric acid 49 ,umole
Isocitric dehydrogenase 25 ,Al
MgCl2 4,mole
Tris buffer, pH 7.4 29 ismole
Microsome fraction 63 mg
DMNA 75 iLmole
D-3 cells 3-5 x 107
Table 4. Recombinogenic properties of DMNA and
DENA following in vitro activation by mouse
liver microsomes.-
Test compound Recombinants
concentration, per 10'
Treatment umole/ml survivors
Control 0 8.3
DMNA
30 min 75 15.4
60 min 75 26.1
DENA
30 min 100 9.1
60 min 100 20.5
aMicrosome fraction was obtained from random-
bred Swiss Albino male mice.
Both compounds are converted to recom-
binogenic intermediates by the liver micro-
somes at concentrations significantly lower
than those required to produce genetic ac-
tivity in the HMA. It appears that DMNA
exhibits greater recombinogenic activity in
this assay than does DENA. Such is also
the case in HMA tests with either bacterial
or yeast cells as indicators. However, in the
enzyme-free hydroxylation system, DENA
shows greater genetic activity for Neuro-
spora (59,60) and yeast (61) than does
DMNA.
The Host-Mediated Assay
Utilization of S. cerevisiae in mouse host-
mediated array (HMA) tests has been de-
scribed (70-72), and a summary of the re-
sults from published literature is presented
in Table 5. An abstract recently published
by Fahrig (73) describes the testing of
DMNA, MMS, 4-nitroquinoline 1-oxide, MN-
NG, and ICR-191 in HMA tests with strain
D-4. The report does not make clear whether
all of the compounds were positive or only
some of them. In addition to the use of
strains D-3 and D-4, we have experimented
with haploid yeast strains in which forward
and reverse mutation could be detected. The
overall results indicated that the least strain
specificity and the maximum degree of sensi-
tivity could be obtained with the diploid
strains.
December 1973 91Table 5. Summary of published host-mediated assay
results with S. cerevisiae as the indicator organism.
Recombinogenic activity
Compound In D-3 In D-4 Reference
EMS + + (71)
Cyclophosphamide + + a (71)
Aryldialkyltriazines NT + (70)
a Activity observed only when cells of D-4 were
exposed to the urine of the treated host.
Specific protocols for the use of yeast cells
in the HMA have been described elsewhere
(70,72). In most respects, yeast cells serve
quite well as genetic indicators in this tech-
nique. Their recovery from the peritoneum
of the host animal is good, with essentially
100%So viability among recovered cells. We
have observed no change in the number of re-
covered D-3 cells during the course of a
4-hr experiment. This may indicate that lit-
tle or no cell division occurs during the in-
cubation or that there is a balance between
growth and lethality maintaining a constant
recoverable population. Good recoveries have
been obtained up to 24 hr after injection,
indicating that relatively long-term expo-
sures are feasible. The injected yeast cells
remain dispersed in the peritoneum and ex-
hibit very little clumping. They can be diluted
and plated immediately following removal
from the sacrificed host.
Results of our yeast HMA tests with sev-
eral compounds are summarized in Table
6. Compounds that are recorded positive
showed either a dose response or were posi-
tive in at least five independent tests but
did not demonstrate a dose response. The
doses shown represent the minimum con-
centrations at which some positive (not nec-
essarily significant) effects were observed.
Generally three or four dose levels were em-
ployed for each chemical. The tests sum-
marized in Table 6 were conducted in ran-
dombred Swiss Albino male mice with 3-hr
exposure period. The peritoneal exudates
from three mice were pooled before being di-
luted and plated. In current tests individual
animals are analyzed and recorded indepen-
Table 6. Summary of host-mediated assay tests with
S. cerevisiae strain D-3 as the indicator organism.
Minimum
effective
Active dose,
Compound in vitro mg/kg Response
EMS + 150 +
MMS + 100 +
DMNA - 1300 +
DENA - 1900 +
Cyclophosphamide + 400 +
Hycanthone + - none at 100 mg/kg
dently. This method provides better analy-
sis of the data and is preferred.
The results in the Table 6 illustrate that
for most compounds high dose levels are
required to produce detectable responses
in yeast. This was also true for our tests
with strain D-4. In fact, we have had con-
sistently better results with strain D-3 than
D-4. A comparison of the strains D-3 and
D-4 with three compounds is presented in
Table 7. The results show clearly that with
similar concentrations of MMS, EMS and
cyclophosphamide, strain D-3 appears to be
more sensitive than D-4. It will be impor-
tant to see how our results compare with
Fahrig's data since many of the same com-
pounds were tested in his laboratory and
ours. Published reports by Siebert (51) also
indicated that cyclophosphamide was not
active in standard HMA tests but that urine
from the treated animals was recombino-
genic. The results in Table 7 were obtained
from analysis of individual animals. Table 8
shows the results of a retest with hycanthone
in which all test and control animals were
assayed individually. The results are consis-
tent with those of the earlier tests.
Summary
Several points should be emphasized re-
garding the use of yeast in genetic assays
conducted as part of the safety evaluation
of chemicals in relation to their risk in the
human population.
Yeast provides a versatile eukaryotic or-
ganism to detect as well as evaluate chem-
Environmental Health Perspectives 192Table 7. Comparison of the induction of reciprocal and nonreciprocal mitotic
recombination in the host-mediated assay with MMS, EMS and cyclophosphamide.
Treatment
3 Controls
MMS
EMS
Cyclophosphamide
Animal
no.
1
2
3
4
5
1
2
3
4
5
Dose,
mg/kg
0
0
0
0
0
100
100
100
100
100
1
2
3
4
5
350
350
350
350
350
1
2
3
4
5
800
800
800
800
800
Reciprocal recombinants
per 10' survivors
0.8 7.4
2.5 0.0
0.5 7.6
3.0 6.1
4.0
Mean 2.2 5.3
9.6
13.0
3.5
6.2
12.1
Mean 8.9
23.0
14.2
5.3
11.4
24.7
Mean 15.7
15.7
13.6
20.2
8.0
16.2
Mean 15.1
Nonreciprocal recombinants
per 105 survivors
1.3 2.0
2.0 3.2
1.1 2.7
0.0 2.4
1.7 2.0
1.3 2.5
2.5
4.4
3.0
3.6
0.0
2.7
1.8
0.0
2.5
2.1
2.3
1.7
2.3
2.2
2.6
2.6
3.2
2.6
a Controls for cyclophosphamide.
icals possessing mutagenic and recombino-
genic activity. Most of the assays in which
bacteria or other microorgansims are used
as plate tests, host-mediated tests and in
vitro microsome-activated assays can be
modified to accommodate some haploid or
diploid strain of yeast. This offers an ideal
situation in which the activity of a particu-
lar compound can be compared to prokaryo-
tic and eukaryotic cell types.
Yeast is uniquely suited for the study of
mitotic recombination and gene conversion.
A number of markers can be conveniently
used for these studies, and the resultant pro-
ducts can be genetically analyzed to define
the type of event that has occurred. Chem-
icals which can induce mitotic recombina-
tion may play a significant role in making
homozygotic those pre-existing or recently
induced recessive mutations in a diploid cell
undergoing mitotic cell division, with the
concomitant effects the expression of the
homozygous alleles might exert on the de-
velopmental, aging and biochemical func-
tions of the individual cell or organism in
which the gene resides. There are sufficient
data reported here and by other investiga-
tors to suggest that the induction of mitotic
recombination exhibits very little or no
chemical specificity and that these events
are often induced at a lower concentration
of the particular chemical than required for
gene mutation induction.
The doses necessary to produce genetic
effects in yeast indicator cells are quite high
in many cases. For example, in the HMA,
DMNA will induce a strong mutagenic re-
sponse in Salmonella strain G-46 at a dose
100 times lower than that required to obtain
an effect in strain D-3 of the yeast. This
December 1973 93Table 8. Effect of hyeanthone in the host-
mediated assay.
Reciprocal
recombinants
Animal Dose, per 105
Treatment no. mg/kg survivors
Control 1 0 1.4
2 0 1.2
3 0 1.0
4 0 1.0
5 0 0.9
6 0 0.9
7 0 0.9
8 0 0.8
9 0 0.8
10 0 0.7
Mean 1.0
Hycanthone 1 100 1.3
2 100 1.1
3 100 1.1
4 100 1.1
5 100 1.1
6 100 1.0
7 100 0.9
8 100 0.8
9 100 0.7
10 100 0.5
Mean 1.0
low sensitivity in yeast compared to bacteria
may result from a number of things, includ-
ing differences in physical parameters such
as cell walls or internal membrane barriers
not present in bacteria. The differences
might also reflect biochemical differences be-
tween the two cell types relating to enzyma-
tic modification of the chemical or the num-
ber of susceptible target sites in the respec-
tive genomes. Obviously there exist qualita-
tive and quantitative differences between
the mutagenic sensitivity and specificity
in pro- and eukaryotic cells, and until the
mechanisms resulting in these differences
are understood, it will be difficult to assess
the relevance of a response obtained from a
given indicator organism to the potential
risk to human cells.
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